Study of AK135 for chemotherapy-induced nerve damage
Part of Brain & nervous system, Cancer, Pain clinical trials.
This trial tests a new medicine called AK135 to see if it can help reduce pain and numbness caused by chemotherapy. It is for people who have ongoing nerve problems after finishing certain cancer treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cancer that has been confirmed by a biopsy or other test.
- You have had chemotherapy that caused nerve damage, and you stopped that treatment at least 1 month ago.
- You still have pain or numbness from the nerve damage, and it is at least moderate in severity.
- You are generally able to take care of yourself (able to walk and do light activities).
- You have not used any treatments for nerve pain within the last 2 weeks.
- You do not have other conditions like diabetes or autoimmune diseases that could also cause nerve problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether acupuncture and compression therapy can prevent nerve damage caused by taxane chemotherapy in early-stage breast cancer. It aims to reduce numbness, tingling, or pain in the hands and feet.
This trial tests if adding electroacupuncture, a gentle type of acupuncture using mild electric pulses, can help relieve nerve pain, tingling, or numbness caused by chemotherapy in people with cancer.
This trial tests whether a drug called GM1 can prevent nerve damage (numbness, tingling, or pain in hands/feet) caused by a common chemotherapy drug used for breast cancer. If you are starting chemotherapy with nab-paclitaxel, this study may help protect your nerves.
This trial is testing a wearable device (gloves and boots) that applies gentle compression to your hands and feet during chemotherapy. It aims to prevent or reduce nerve damage (numbness, tingling, pain) that some chemotherapy drugs can cause.
This study tests a new medicine (JMKX000189) to see if it can safely reduce nerve pain, tingling, or numbness that comes from chemotherapy. If you have this side effect after cancer treatment, this trial might offer a new way to feel better.
This study looks for small molecules in the blood that might predict nerve damage caused by certain chemotherapies. If you have colorectal or lung cancer and are starting a specific chemo plan, this trial could help researchers understand why some people get nerve problems and others don't.
Hear when a new Chemotherapy-induced Peripheral Neuropathy (CIPN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.